|
1 |
A prognostic neural epigenetic signature in high-grade glioma
Drexler, Richard. - Aachen : Universitätsbibliothek der RWTH Aachen, 2024
|
|
|
|
2 |
Mid-term treatment-related cognitive sequelae in glioma patients
Schlömer, Sabine. - Bochum : Ruhr-Universität Bochum, 2022
|
|
|
|
3 |
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
Lim, Michael. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2022
|
|
|
|
4 |
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial
Omuro, Antonio. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2022
|
|
|
5 |
A tumor-promoting role for soluble TβRIII in glioblastoma
Enthalten in Molecular and cellular biochemistry 26.3.2021: 1-11
|
|
|
|
6 |
Endoglin and TGF-β signaling in glioblastoma
Enthalten in Cell & tissue research 20.1.2021: 1-12
|
|
|
|
7 |
YAP1-fusions in pediatric NF2-wildtype meningioma
Sievers, Philipp. - Augsburg : Universität Augsburg, 2020
|
|
|
|
8 |
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Enthalten in Nature reviews / Clinical oncology 8.12.2020: 1-17
|
|
|
|
9 |
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma
Paramasivam, Nagarajan. - Augsburg : Universität Augsburg, 2019
|
|
|
|
10 |
Hypoxia enhances the antiglioma cytotoxicity of b10, a glycosylated derivative of betulinic acid
Frankfurt am Main : Univ.-Bibliothek Frankfurt am Main, 2014
|
|
Administration
